ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 365 out of 1677

$537K Total Retail Price of All Prescriptions

Rank: 318 out of 1677

410 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,218 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
PRAVASTATIN SODIUM 660 423 1 10
AMLODIPINE BESYLATE 488 333 2 2
LISINOPRIL 323 208 3 3
LEVOTHYROXINE SODIUM 318 281 4 5
HYDROCODONE-ACETAMINOPHEN 255 162 S3 5 4
METFORMIN HCL 232 153 6 7
OMEPRAZOLE 227 145 7 6
FUROSEMIDE 210 141 8 8
METOPROLOL TARTRATE 184 113 9 12
NEXIUM 182 110 10 19
GABAPENTIN 168 100 11 11
METOPROLOL SUCCINATE 152 112 12 23
ATORVASTATIN CALCIUM 152 125 12 13
CRESTOR 152 119 12 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 93 15 17
AMLODIPINE BESYLATE-BENAZEPRIL 140 81 16 59
FLUOXETINE HCL 137 75 17 49
ZOLPIDEM TARTRATE 133 71 18 15
TRAMADOL HCL 126 89 19 16
FAMOTIDINE 125 46 20 41
SERTRALINE HCL 117 75 21 26
HYDROCHLOROTHIAZIDE 113 47 22 9
LANTUS SOLOSTAR 107 74 23 132
POTASSIUM CHLORIDE 103 49 24 14
CLOPIDOGREL 96 70 25 32
RANITIDINE HCL 95 43 26 18
MELOXICAM 90 52 27 27
JANUVIA 90 70 27 70
FLUTICASONE PROPIONATE 89 49 29 29
PEN NEEDLE 76 46 30 164
PLAVIX 75 59 31 47
DONEPEZIL HCL 75 75 31 30
TAMSULOSIN HCL 72 60 33 34
LANTUS 72 51 33 44
WARFARIN SODIUM 71 56 35 24
CITALOPRAM HBR 71 58 35 22
GLIMEPIRIDE 71 36 35 33
CYMBALTA 69 47 38 58
FENOFIBRATE 67 57 39 48
PROAIR HFA 66 18 40 50
LOSARTAN-HYDROCHLOROTHIAZIDE 66 31 40 42
DIOVAN HCT 66 63 40 66
SPIRIVA 64 38 43 74
ALLOPURINOL 64 48 43 31
VENLAFAXINE HCL ER 62 31 45 92
LOSARTAN POTASSIUM 60 45 46 25
PANTOPRAZOLE SODIUM 56 42 47 46
ATENOLOL 56 34 47 21
BYSTOLIC 55 34 49 125
NOVOLOG FLEXPEN 52 30 50 250
NAPROXEN 52 25 50 87
INSULIN SYRINGE 51 23 52 72
ADVAIR DISKUS 50 31 53 54
BUPROPION XL 50 30 53 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.